Partnering on vaccines to counter multi-drug resistant threats: Workshop proceedings, Biomedical Advanced Research and Development Authority by Julie N. Bergmann, Rushyannah R. Killen-Cade, Lindsay A. Parish, Mark T. Albrecht, Daniel N. Wolfe

“…On March 12, 2021, the Biomedical Advanced Research and Development Authority (BARDA) sponsored a virtual market research workshop, “Partnering on Vaccines to Counter Multi-Drug Resistant Threats,” to discuss the threat of antimicrobial resistance in the context of BARDA’s mission space and the challenges encountered during the development of vaccines for specific antimicrobial resistant bacteria. …”
Get full text

Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA) by Lindsay A. Parish, Eric J. Stavale, Christopher R. Houchens, Daniel N. Wolfe

“…During the recent outbreak of SUDV virus disease, the Biomedical Advanced Research and Development Authority (BARDA), as part of the Administration for Strategic Preparedness and Response within the U.S. …”
Get full text

Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults by Christine M. Oshansky, James King, Di Lu, James Zhou, Corrina Pavetto, Gary Horwith, Karen Biscardi, Bai Nguyen, John J. Treanor, Li-Mei Chen, Brett Jepson, BPI17002 Study Coordination Team, Rick A. Bright, Robert A. Johnson, Vittoria Cioce, Ruben O. Donis

Get full text

Blood product use for radiological/nuclear trauma: product development and US regulatory considerations by Toby A Silverman, Annette M Shadiack, Kimberly A Hofmeyer, Ashley E Cecere, Derek L Eisnor, Corey M Hoffman, Shannon G Loelius, Aditiben Patel, Mary J Homer

Get full text

Advancing development of medical countermeasures: Incorporating COVID-19 lessons learned into future pandemic preparedness planning by Robert A. Johnson, Richard C. White, Gary L. Disbrow

Get full text

Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus by Daniel N. Wolfe, Marva J. Taylor, Amanda G. Zarrabian

Get full text

A framework for future national pediatric pandemic respiratory disease severity triage: The HHS pediatric COVID-19 data challenge by Timothy Bergquist, Marie Wax, Tellen D. Bennett, Richard A. Moffitt, Jifan Gao, Guanhua Chen, Amalio Telenti, M. Cyrus Maher, Istvan Bartha, Lorne Walker, Benjamin E. Orwoll, Meenakshi Mishra, Joy Alamgir, Bruce L. Cragin, Christopher H. Ferguson, Hui-Hsing Wong, Anne Deslattes Mays, Leonie Misquitta, Kerry A. DeMarco, Kimberly L. Sciarretta, Sandeep A. Patel

Get full text

Publisher Correction: Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial by Youyi Fong, Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo, Alice McGarry, Lisa M. Dunkle, Iksung Cho, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Christos J. Petropoulos, Andrew Leith, Deanne Haugaard, Bill Webb, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, April K. Randhawa, Michele P. Andrasik, James G. Kublin, Julia Hutter, Maryam Keshtkar-Jahromi, Tatiana H. Beresnev, Lawrence Corey, Kathleen M. Neuzil, Dean Follmann, Julie A. Ake, Cynthia L. Gay, Karen L. Kotloff, Richard A. Koup, Ruben O. Donis, Peter B. Gilbert, Immune Assays Team, Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team, United States Government (USG)/CoVPN Biostatistics Team

Get full text

Utilization of Viral Vector Vaccines in Preparing for Future Pandemics by Kimberly A. Hofmeyer, Katherine M. Bianchi, Daniel N. Wolfe

Get full text

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial by Youyi Fong, Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo, Alice McGarry, Lisa M. Dunkle, Iksung Cho, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Christos J. Petropoulos, Andrew Leith, Deanne Haugaard, Bill Webb, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, April K. Randhawa, Michele P. Andrasik, James G. Kublin, Julia Hutter, Maryam Keshtkar-Jahromi, Tatiana H. Beresnev, Lawrence Corey, Kathleen M. Neuzil, Dean Follmann, Julie A. Ake, Cynthia L. Gay, Karen L. Kotloff, Richard A. Koup, Ruben O. Donis, Peter B. Gilbert, Immune Assays Team, Coronavirus Vaccine Prevention Network (CoVPN)/2019nCoV-301 Principal Investigators and Study Team, United States Government (USG)/CoVPN Biostatistics Team

Get full text

The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next Steps by Ian Crozier, Kyla A. Britson, Daniel N. Wolfe, John D. Klena, Lisa E. Hensley, John S. Lee, Larry A. Wolfraim, Kimberly L. Taylor, Elizabeth S. Higgs, Joel M. Montgomery, Karen A. Martins

Get full text

Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine by David Benkeser, Youyi Fong, Holly E. Janes, Elizabeth J. Kelly, Ian Hirsch, Stephanie Sproule, Ann Marie Stanley, Jill Maaske, Tonya Villafana, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Victor Ayala, Christos J. Petropoulos, Andrew Leith, Deanne Haugaard, Bill Webb, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Lindsay N. Carpp, April K. Randhawa, Michele P. Andrasik, James G. Kublin, Margaret Brewinski Isaacs, Mamodikoe Makhene, Tina Tong, Merlin L. Robb, Lawrence Corey, Kathleen M. Neuzil, Dean Follmann, Corey Hoffman, Ann R. Falsey, Magdalena Sobieszczyk, Richard A. Koup, Ruben O. Donis, Peter B. Gilbert, on behalf of the AstraZeneca AZD1222 Clinical Study Group, the Immune Assays Team, the United States Government (USG)/CoVPN Biostatistics Team

Get full text

Efficacy of different AV7909 dose regimens in a nonclinical model of pulmonary anthrax by Lisa Henning, Michael Anderson, Cheryl Triplett, Tammy Smith, Kevin Boyce, Lindsay Hendey, Alex Ridenour, Jason Eng, David Schaeufele, Ehran Wilson, Carol L. Sabourin, Lily E. Adams, Tahar Babas, Lindsay Parish, Daniel Wolfe

Get full text

Selection of Filovirus Isolates for Vaccine Development Programs by Daniel N. Wolfe, Carol L. Sabourin, Michael J. Merchlinsky, William C. Florence, Larry A. Wolfraim, Kimberly L. Taylor, Lucy A. Ward

Get full text

Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report by Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, Rebecca Farkas, Shobana Balasingam, Karin Bok, Ursula J. Buchholz, M. Patricia D’Souza, Jennifer L. Gordon, Deborah F. L. King, Tung T. Le, Wolfgang W. Leitner, Robert A. Seder, Alkis Togias, Stig Tollefsen, David W. Vaughn, Daniel N. Wolfe, Kimberly L. Taylor, Anthony S. Fauci

“…On November 7th and 8th, 2022, The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), The Coalition for Epidemic Preparedness Innovation (CEPI), The Bill & Melinda Gates Foundation (BMGF), The Biomedical Advanced Research and Development Authority (BARDA), and the Wellcome Trust hosted a virtual workshop entitled “Mucosal Vaccines for SARS-CoV-2: Scientific Gaps and Opportunities.” …”
Get full text

Mathematical modeling of the West Africa Ebola epidemic by Jean-Paul Chretien, Steven Riley, Dylan B George

Get full text

Current State of Anthrax Vaccines and Key R&D Gaps Moving Forward by Adam Clark, Daniel N. Wolfe

Get full text

Exploring Early Pre-Symptomatic Detection of Influenza Using Continuous Monitoring of Advanced Physiological Parameters during a Randomized Controlled Trial by Nir Goldstein, Arik Eisenkraft, Carlos J. Arguello, Ge Justin Yang, Efrat Sand, Arik Ben Ishay, Roei Merin, Meir Fons, Romi Littman, Dean Nachman, Yftach Gepner

Get full text

Natural History of Marburg Virus Infection to Support Medical Countermeasure Development by Jason E. Comer, Trevor Brasel, Shane Massey, David W. Beasley, Chris M. Cirimotich, Daniel C. Sanford, Ying-Liang Chou, Nancy A. Niemuth, Joseph Novak, Carol L. Sabourin, Michael Merchlinsky, James P. Long, Eric J. Stavale, Daniel N. Wolfe

“…The Biomedical Advanced Research and Development Authority, part of the Administration for Strategic Preparedness and Response within the U.S. …”
Get full text

SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Ac... by Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, Richard Wang, Fernando Echegaray, Lisa Bentley, Ann E. Eakin, Karl J. Erlandson, Leah C. Katzelnick, Carol D. Weiss, Wei Wang

Get full text